Document is current
Any future updates will be listed below
-
Authors
Patel, Nishaben M. https://orcid.org/0000-0003-4724-5710
Ripoll, Léa https://orcid.org/0000-0002-9620-1098
Peach, Chloe J.
Ma, Ning https://orcid.org/0000-0003-4653-7797
Blythe, Emily E. https://orcid.org/0000-0001-6363-2644
Vaidehi, Nagarajan https://orcid.org/0000-0001-8100-8132
Bunnett, Nigel W. https://orcid.org/0000-0003-3367-0644
von Zastrow, Mark
Sivaramakrishnan, Sivaraj https://orcid.org/0000-0002-9541-6994
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35-GM126940)
- License Information
-
More Information
Article History
Received: 30 May 2024
Accepted: 26 November 2024
First Online: 6 December 2024
Competing interests
: S.S. is co-founder of Oxbow Therapeutics, LLC. N.W.B is a founding scientist of Endosome Therapeutics. The remaining authors declare no competing interests.
